[isatrader]

I highlighted that CYTK was attempting to move into a new Stage 2A on the weekly chart on Tuesday here: http://stageanalysis.net/forum/showthrea...80#pid4080 but news out today on a failed product development have seen it's shares have an extreme plunge back into Stage 4 territory. And so it should be removed from the watchlist now.

It's a very good example of why Biotech is a very risky area to trade in, as disappointing drug trials etc, can often lead to extreme share price moves that are much less common in other sectors of the market.